Emconcor and respiratory disorder Patient Reports February 13, 2012

Emconcor Side Effects Report #4577434-8
Emconcor side effect was reported by a Consumer or non-health professional from on Jan 24, 2005. Female patient, 88 years of age, was diagnosed with atrial fibrillation  and was treated with Emconcor. After drug was administered, patient experienced the following side effects: bradycardia, electrocardiogram qt prolonged, respiratory disorder. Emconcor dosage: 5 MG, ORAL. During the same period patient was treated with PERSANTIN DEPOT, NITROMEX, CHLOROMYCETIN, PROPAVAN, BEHEPAN, FUROSEMIDE, AMILORID NM PHARMA, ASPIRIN. Patient was hospitalized. Patient recovered.